RDIF announced the start of the third phase of the coronavirus vaccine trial :: Society :: RBC

Photo: press service of the RF Ministry of Defense / RIA Novosti

Post-registration clinical trials of a coronavirus vaccine are starting in Moscow, 40 thousand people will take part in the study. This is stated in the message of the Russian Direct Investment Fund (RDIF), received by RBC.

Russian Direct Investment Fund, Sovereign Fund of the Russian Federation, Moscow Government and National Research Center for Epidemiology and Microbiology named after N.F. The Gamaleis announce the start of a post-registration clinical trial, ”the message says.

Gamaleya Center eliminated the need to take tests before vaccination

With the support of RDIF, tests will be carried out in five more countries.

Russians over 18 years old with a Moscow compulsory medical insurance policy can participate in the study. In addition, candidates should not be sick with SARS, not have contact with those infected with coronavirus at least two weeks before the start of vaccination, and also not be sick with COVID-19.


Share on facebook
Share on pinterest
Share on twitter
Share on linkedin
Share on email


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.